Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's earnings call reveals mixed signals. Integrated Care shows strong EBITDA growth and disciplined cost management, but BetterHelp faces revenue decline and margin pressure. The Q&A indicates positive developments in product innovation and insurance rollout, but challenges remain in scaling and efficiency. The strategic shift to visit-based models and international growth for BetterHelp are promising. However, the lack of clear guidance on certain metrics and the cautious outlook on ACA enrollment impact balance the sentiment. Given the small-cap nature, these mixed factors suggest a neutral stock price movement in the short term.
Key Financial Performance
Consolidated Revenue $614 million, representing a 9.5% margin. The revenue exceeded the midpoint of guidance ranges due to solid performance in Integrated Care and progress in scaling insurance of BetterHelp.
Adjusted EBITDA $58 million, representing a 9.5% margin. This was driven by disciplined cost management and revenue upside.
Net Loss Per Share $0.36, which includes amortization of intangible assets ($0.50), stock-based compensation ($0.08), and restructuring costs ($0.07).
Free Cash Flow Net outflow of $26 million, ending with $751 million in cash and cash equivalents on the balance sheet. This reflects historical seasonality.
Integrated Care Revenue $395 million, an increase of 1.5% year-over-year. Growth was driven by acquisitions (170 basis points contribution) and a high single-digit increase in visit revenue, offset by lower subscription revenues.
Chronic Care Program Enrollment 1.2 million, up approximately 1% sequentially and 4% year-over-year. Growth was driven by increased adoption of multi-condition bundles by clients.
Integrated Care Adjusted EBITDA $56 million, up 12% year-over-year, representing a 14.2% margin. This was driven by revenue upside and disciplined cost management, offsetting mix-related gross margin pressure.
BetterHelp Revenue $218 million, 9% lower year-over-year. Decline was due to pressure on the direct-to-consumer cash pay business, partially offset by $13 million in insurance-based revenue.
BetterHelp Adjusted EBITDA $2 million, representing a 0.9% margin, down from 3.2% in the prior year. Lower cash pay revenue and investments in insurance rollout drove the decline, partially offset by reduced advertising and marketing expenses.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Enhanced 24/7 care offering: Broadened conditions addressed, added specialist support, real-time prescription benefit checks, and expanded in-network care connections.
AI-driven product innovation: Developing new products leveraging clinical services and AI-enabled capabilities for release later this year.
Mental health services: Generated nearly $140 million in annual revenue for mental health services in 2025, with further growth in Q1 2026.
BetterHelp insurance rollout: Expanded to 30 states and Washington, D.C., with over 6,000 providers credentialed and enrolled, and 150 million insurance-contracted lives.
International expansion: Localized country launches in 2025 showed solid growth; targeting 1-2 new markets in the second half of 2026.
AI-assisted clinical documentation: Reduced administrative burden for therapists, saving 15 minutes per session and over 4 million minutes in total.
Cost structure alignment: Focused on operating efficiency and effectiveness, leveraging AI to enhance productivity.
Shift to visit-based arrangements: Adapted to client preferences moving from subscription-based access to visit-based models, creating new opportunities.
BetterHelp insurance strategy: Shifted from cash-pay to insurance-based model, improving activation and stabilizing trends in key markets.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Shift from subscription-based to visit-based arrangements: The transition from subscription-based access to visit-based arrangements has created near-term changes to the business model, leading to revenue headwinds. This shift requires adaptation to align with the fee-for-service construct of the U.S. healthcare system.
Chronic care market fragmentation: The proliferation of point solutions in the chronic care market has increased fragmentation, posing challenges for delivering integrated and comprehensive care solutions.
Pressure on BetterHelp's U.S. cash pay business: BetterHelp's direct-to-consumer cash pay business is under pressure due to challenging consumer conditions, impacting revenue and requiring a shift towards insurance-based models.
Integration and scaling of insurance for BetterHelp: The rollout of insurance for BetterHelp, while progressing, requires significant investment and operational adjustments, impacting short-term margins and profitability.
Operational cost management: The need for disciplined cost management and productivity improvements is critical to offset mix-related gross margin pressures and ensure financial sustainability.
Debt management and financial stability: The company faces the challenge of addressing its 2027 convertible notes, requiring a phased approach to reduce gross debt and maintain financial strength.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance for 2026: Consolidated revenue is expected to be in the range of $2.48 billion to $2.58 billion, with the midpoint unchanged from prior outlook.
Adjusted EBITDA Guidance for 2026: Expected to be in the range of $267 million to $306 million, with the midpoint unchanged from prior outlook.
Free Cash Flow Guidance for 2026: Expected to be in the range of $130 million to $170 million, with the midpoint unchanged from prior outlook.
Stock-Based Compensation Expense for 2026: Projected to be below $55 million, representing a decline of over 30% from 2025 and over 70% since 2023.
Second Quarter 2026 Revenue Guidance: Expected to be in the range of $597 million to $626 million.
Second Quarter 2026 Adjusted EBITDA Guidance: Expected to be in the range of $55 million to $67 million.
Integrated Care Revenue Growth for 2026: Expected to grow 0.8% to 3.5% for the year, with high single-digit growth in visit revenues offset by lower subscription revenue.
BetterHelp Revenue Guidance for 2026: Expected to decline 6.5% to 1.0% compared to 2025, with insurance revenue projected in the range of $90 million to $105 million.
BetterHelp Insurance Revenue Exit Run Rate for 2026: Expected to reach at least $125 million in the fourth quarter.
BetterHelp Second Quarter 2026 Revenue Guidance: Expected to decline 11.75% to 5.25% year-over-year, with insurance revenue projected in the range of $18 million to $22 million.
BetterHelp Adjusted EBITDA Margin for 2026: Guidance remains at 3.0% to 4.6%, reflecting mix impacts and investments to scale insurance.
Integrated Care Adjusted EBITDA Margin for 2026: Guidance remains at 15.1% to 16.1%, with margin improvement driven by cost savings and productivity initiatives.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the company's outlook on the return to growth for Integrated Care and BetterHelp?
A:The company expects a shift from subscription-based to visit-based models, with 70% of memberships in visit-based arrangements by the end of 2026. Growth is anticipated to become a net tailwind starting in the third quarter of this year. For BetterHelp, the insurance entry point is scaling well, reducing cost barriers, and increasing session numbers. International growth is also contributing to BetterHelp's turnaround.
Q:What factors impacted the first and second quarter guidance for Integrated Care?
A:The first quarter saw a beat due to timing and nonrecurring factors, including an earlier booking and delayed contract implementations. The second quarter guidance reflects these adjustments, with expectations for a more weighted revenue split in the second half of the year.
Q:What is the company's approach to product innovation in Integrated Care?
A:The company is focused on driving greater value for clients through product innovation, including new comprehensive solutions to be rolled out later in the year. These innovations aim to leverage the company's core strengths and provide more comprehensive services.
Q:What are the assumptions for ACA subsidy-related disenrollment and its impact on Integrated Care?
A:The company expects continued moderation in ACA enrollment throughout the year, which has been reflected in their guidance. However, they do not anticipate a material impact on revenues or visits due to the nature of the membership mix.
Q:What are the drivers and challenges for the BetterHelp insurance rollout?
A:The insurance rollout is progressing well, with higher funnel conversion and increased session numbers. Challenges include ensuring adequate therapist capacity to meet demand. The company has credentialed over 6,000 providers and continues to scale its therapist network.
Q:What is the company's outlook on the Chronic Care business and selling season?
A:The company sees stabilization and momentum in the Chronic Care business, with bundled products making up 70% of offerings. Early signs in the selling season are encouraging, with higher win ratios and strategic client conversations. Product innovation and comprehensive solutions are expected to drive growth.
Q:What is the company's stance on GLP-1 prescribing and product innovation in Chronic Care?
A:The company focuses on patient care and outcomes rather than prescribing GLP-1s. They aim to offer wraparound services and leverage their product portfolio for broader weight and obesity management solutions.
Q:What are the company's initiatives to monetize Integrated Care members and drive revenue growth?
A:The company is leveraging its scaled platform and integrated approach to connect services and activate new revenue streams. Innovations like the 24/7 enhanced care offering aim to broaden services and improve patient engagement.
Q:What is the company's progress and challenges in scaling BetterHelp insurance to all states?
A:The company expects to be in substantially all states by the end of the year, with 30 states already live. Challenges include payer contracts and therapist credentialing, but progress is ahead of schedule.
Q:What is the company's outlook on BetterHelp margins and ad spend efficiency?
A:BetterHelp insurance has lower gross margins than direct-to-consumer but offers opportunities for margin expansion through ad spend efficiency and operating leverage. The company is exploring new advertising strategies to improve efficiency as insurance scales.
Q:What is the company's visibility on the ramp and utilization of visit-based contracts in Integrated Care?
A:The company has good visibility on the implementation of delayed contracts in the second half of the year. The shift to visit-based models is expected to be a net tailwind, with continued growth in visit revenues.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the average co-pay for insurance-covered patients on BetterHelp compared to cash pay. Additionally, they did not clarify the exact timeline for the CFO search or provide detailed metrics on ad spend efficiency improvements.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Colby conference
Conference Instructions
Health Conference
Instructions result
Ladies gentleman
President Investor
Relations afternoon
Teladoc Health
Vice President
conference today
gentleman name
measure Vice
name Colby
result Chief
today Teladoc
website Details
TDOC Transcript
Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript
Unknown4-30
The company's earnings call reveals mixed signals. Integrated Care shows strong EBITDA growth and disciplined cost management, but BetterHelp faces revenue decline and margin pressure. The Q&A indicates positive developments in product innovation and insurance rollout, but challenges remain in scaling and efficiency. The strategic shift to visit-based models and international growth for BetterHelp are promising. However, the lack of clear guidance on certain metrics and the cautious outlook on ACA enrollment impact balance the sentiment. Given the small-cap nature, these mixed factors suggest a neutral stock price movement in the short term.
Teladoc Health, Inc. (TDOC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
Teladoc Health, Inc. (TDOC) Q4 2025 Earnings Call Transcript
Unknown2-26
Despite some positive indicators such as insurance rollout and international growth, challenges remain, particularly with BetterHelp's declining revenue and competition in the U.S. market. The Q&A session revealed mixed feedback on strategic discussions and uncertainties in guidance, leading to a neutral sentiment overall.
Teladoc Health, Inc. (TDOC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
TDOC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
